Merial Select, in Gainesville, Georgia, and the Merial Avian Global Enterprise offer a comprehensive selection of vaccines and delivery systems that offer protection from many important poultry health challenges. These include vaccines against Marek's disease, infectious bursal disease, Newcastle disease, infectious bronchitis and many others. Merial Select is part of Merial, headquartered in Duluth, Georgia, which is a worldwide animal healthcare company with a global total market share of more than 14 percent and a network of 16 manufacturing sites and eight R&D facilities.

Nature of GRA support: Merial Select has joined with GRA Eminent Scholar Egbert Mundt at the University of Georgia in a multifaceted research collaboration to develop poultry vaccine platforms.